It declared an interim dividend of Rs 5 per equity share of Rs 5 each.
After surging 12.5 per cent to Rs 534.80 -- 52-week high on the BSE in intra-day trading -- Torrent Pharma's scrip finally closed at Rs 507.85, up 6.84 per cent.
On the NSE, the stock climbed 7.76 per cent to close at Rs 510.60.
The company had yesterday reported 41 per cent increase in consolidated net profit for the third quarter ended December 31 to Rs 158 crore on the back of robust sales.
Net sales during the quarter stood at Rs 990 crore, compared to Rs 768 crore in the year-ago period.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
